Evaluation saliva specimen zidovudine therapy HIV-infected patients studies pharmacokinetic properties zidovudine relationship plasma salivary concentrations drug oral dosage HIV-infected patients Zidovudine concentrations plasma unstimulated mixed saliva citric-acid-stimulated mixed saliva period hours high-performance liquid chromatography Correlation coefficients saliva plasma unstimulated saliva average values unstimulated saliva plasma stimulated saliva saliva values total concentration unbound drug plasma half-life time saliva pharmacokinetic parameters good correlation types specimen findings convenience sample collection citric-acid-stimulated saliva appropriate specimen zidovudine therapy 